Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Allied Critical Metals Extends Santa Helena Zone with 6.0m of 1.02% WO3 at Borralha (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Devonian Health Group Inc
V.GSD
Alternate Symbol(s):
DVHGF
Healthcare
Biotechnology
Devonian Health Group Inc. is a clinical-stage pharmaceutical company. It specializes in the development of drugs for various autoimmune inflammatory conditions with novel therapeutic approaches to targeting unmet medical needs. It is developing prescription drugs for the treatment of inflammatory autoimmune diseases, including but not limited to, ulcerative colitis and atopic dermatitis. It is also involved in the development of cosmeceutical products, leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health problems related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., sells prescription pharmaceutical products.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
New Post
TSXV:GSD - Post by User
Devonian Health Group Inc
<< Previous
Bullboard Posts
Next >>
(276)
•••
wallywagon
X
Post by
wallywagon
on Oct 10, 2024 6:45pm
145 Views
Post# 36261872
Granting of More Stock Options.....
Granting of More Stock Options.....
For What? A job well done? WTF!!!??? How about creating shareholder value like in increased share price? Then Mgmt can reward themselves because they deserve it. THEY DON'T DESERVE IT
This is such B.S. Pierre was an incompetent leader. Luc even worse. Done squat
NO RESULTS at all. No Phase 3. No Buying. No interest. Just lots of excuses
The storm is coming. Massive selloff of disgruntled shareholders . Look at that sell order for over 200K shares at 16 cents. God save us
Filed
2024-10-09
10:43
Tx date
2024-10-08
$GSD
Devonian Health Group Inc.
Boulet, Andr
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+937,500
vol
3,112,500
Filed
2024-10-09
10:40
Tx date
2024-10-08
$GSD
Devonian Health Group Inc.
Montanaro, Pierre J.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,250,000
vol
1,900,000
Filed
2024-10-09
08:18
Tx date
2024-10-08
$GSD
Devonian Health Group Inc.
Gregoire, Luc
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,111,111
vol
7,030,332
<< Previous
Bullboard Posts
Next >>
Take advantage of setbacks among industry leaders: A strategic entry into Almonty Industries, Rheinmetall, and D-Wave Quantum
Jet maker Bombardier soars into Q4
NSXA Acquisition, Gold Volatility & Global Trends | The Market this Month, Ep 10 of 2025
Nuclear power, uranium, and global energy trends
Does Germany have a drone problem? Hensoldt, TKMS, Helsing, and NEO Battery Materials!
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
{{ dialogTitle }}
×
Reject Reason
{{ policy.description }}
{{reasonError}}
Additional Comments
{{feedbackError}}
{{buttonTitle}}
Cancel
{{submitMsg}}
Featured News Links
Get into THE next Gold Play at ground level — Ripasso invites investors in at launch